Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luis, Balbiani"'
Autor:
Graciela Caccia, Jeannette Rodger, Celia Brosio, Elizabeth Mickiewicz, Luis Riva Gonzáles, Luis Balbiani, Daniel Flores Morales, Carlos Delfino, Alberto Zori Comba
Publikováno v:
Oncology. 66:18-23
Objectives: To assess the efficacy and tolerability of gemcitabine and paclitaxel as first-line treatment in advanced breast cancer. Methods: Patients with histologically confirmed metastatic or metastatic plus locally advanced breast cancer received
Autor:
Francisco Lastiri, Marcelo Muino, José Luis Castilla, S. Jovtis, Luis Balbiani, Mariana Abal, Roberto Pinckevicius, Adolfo Marantz, D. Lewi, Silvia Agusto, Eduardo Almira, Graciela Pasccon, Graciela Uranga, Luis Fein, Mónica Reale
Publikováno v:
Seminars in Oncology. 28:44-49
The primary goal of this phase II study was to determine the efficacy of gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) plus 5-fluorouracil in patients with pancreatic cancer. Eligibility criteria included nonresectable locally advance
Autor:
Gonzalo Recondo, Elizabeth Mickiewicz, F. Pujol, M. Vilanova, M. Montiel, A. Zori Comba, Luis Balbiani, C. Blajman, A. Schmilovich, Eduardo Richardet, E. Cazap, F. Lastiri, J. Simon, E. Wasserman, S. Bella, M. Chacon, M. Van Kooten, F. Coppola, R. Giglio, Jeannette Rodger, F. Perazzo
Publikováno v:
European Journal of Cancer. 37:1006-1013
The aim of this study was to examine the efficacy and safety of both oxaliplatin as a single agent and oxaliplatin in combination with daily×5 bolus 5-fluorouracil and folinic acid (5-FU/FA, Mayo clinic regimen) in the first-line treatment of metast
Autor:
Carlos E. Araujo, Luis Balbiani, Claudio Savulsky, Juan C. Cervellino, Carlos Sparrow, Mario F. Bruno, Norberto Brocato, Guillermo Temperley, Claudia Pirisi
Publikováno v:
Oncology. 52:24-31
203 patients with inoperable non-small cell lung cancer (NSCLC) were randomized to receive ifosfamide (IFO) 2.5 g/m2 days 1-2 + epirubicin (EPI) 70 mg/m2 day 1 with cisplatin (DD
Autor:
Carlos, Delfino, Graciela, Caccia, Luis, Riva Gonzáles, Elizabeth, Mickiewicz, Jeannette, Rodger, Luis, Balbiani, Daniel, Flores Morales, Alberto, Zori Comba, Celia, Brosio
Publikováno v:
Oncology (Williston Park, N.Y.). 17(12 Suppl 14)
Gemcitabine (Gemzar) and paclitaxel exhibit good activity and good safety profiles when used alone and together in the treatment of advanced breast cancer. In a phase II trial, 45 patients with metastatic breast cancer received gemcitabine at 1,200 m
Autor:
Adolfo Marantz, Silvia Jovtis, Eduardo Almira, Luis Balbiani, Jos[eacute] Luis Castilla, Luis Fein, Daniel Lewi, Graciela Pasccon, Roberto Pinckevicius, Graciela Uranga, Mariana Abal, Marcelo Mui[ntilde]o, M[oacute]nica Reale, Silvia Agusto
Publikováno v:
Seminars in oncology. 28(3 Suppl 10)
The primary goal of this phase II study was to determine the efficacy of gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) plus 5-fluorouracil in patients with pancreatic cancer. Eligibility criteria included nonresectable locally advance